Transgenic Animals: The promise and peril of genetic modifications

Background: Transgenic animals, developed through genetic engineering techniques, have revolutionized biomedical research, agriculture, and pharmaceutical production. By introducing foreign DNA into animal genomes, scientists have enhanced traits such as disease resistance, improved food production, and enabled the generation of biopharmaceuticals. Despite these advancements, concerns regarding ethical implications, biosafety, and environmental risks remain. This review explores the methodologies, applications, and potential risks associated with transgenic animal technology. Methods: A comprehensive literature review was conducted, analyzing peer-reviewed articles and experimental studies on transgenic animal technology. Key methods used in generating transgenic animals, including vector-mediated gene transfer, DNA microinjection, sperm-mediated gene transfer, testis-mediated gene transfer, and somatic cell nuclear transfer (SCNT), were critically examined. Results: Transgenic animals have yielded significant advancements in medicine, including the production of recombinant proteins, disease models, and potential organ donors for xenotransplantation. In agriculture, genetic modifications have improved livestock productivity, enhanced nutritional value, and contributed to food security. However, the peril of this genetic modifications of animals, such as unintended genetic mutations and potential biodiversity loss, necessitate stringent biosafety regulations. Conclusion: While transgenic animals hold immense promise in scientific and medical advancements, their applications must be balanced with ethical considerations and environmental safety measures. Continued research, regulatory oversight, and public engagement are essential to maximize benefits while mitigating risks. Advancements in gene-editing technologies, such as CRISPR, may further enhance the precision and efficiency of transgenic modifications in the future.